个人中心 - 老虎社区

Sharontankh

IP属地：未知

帖子 · 3帖子 · 3
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- SharontankhSharontankh
  ·2021-04-23
  Too late to buy
  Why Ocugen Shares Skyrocketed Today
  Ocugen Inc OCGN 42.92% shares soared 42.9% in the regular session and another 11% in the after-hours
  Why Ocugen Shares Skyrocketed Today
  240 1
  4
  分享
  举报
- SharontankhSharontankh
  ·2021-04-23
  Buy more
  非常抱歉，此主贴已删除
  292 2
  3
  分享
  举报
- SharontankhSharontankh
  ·2021-04-21
  👍
  Coca-Cola Prices Set To Rise Amid Soaring Cost Pressures
  The price of a refreshing Coca-Cola is set to rise as the beverage company offsets higher commodity
  Coca-Cola Prices Set To Rise Amid Soaring Cost Pressures
  204 评论
  3
  分享
  举报
暂无粉丝

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3581994063253199","uuid":"3581994063253199","gmtCreate":1618900204136,"gmtModify":1618900204136,"name":"Sharontankh","pinyin":"sharontankh","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":9,"tweetSize":3,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.18","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":376701396,"gmtCreate":1619146011315,"gmtModify":1634288201972,"author":{"id":"3581994063253199","authorId":"3581994063253199","name":"Sharontankh","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581994063253199","idStr":"3581994063253199"},"themes":[],"htmlText":"Too late to buy","listText":"Too late to buy","text":"Too late to buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/376701396","repostId":"1137961906","repostType":4,"repost":{"id":"1137961906","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1619145390,"share":"https://www.laohu8.com/m/news/1137961906?lang=&edition=full","pubTime":"2021-04-23 10:36","market":"us","language":"en","title":"Why Ocugen Shares Skyrocketed Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1137961906","media":"Benzinga","summary":"Ocugen Inc OCGN 42.92% shares soared 42.9% in the regular session and another 11% in the after-hours","content":"<p><b>Ocugen Inc</b>&nbsp;OCGN 42.92%&nbsp;shares soared 42.9% in the regular session and another 11% in the after-hours session on Thursday.</p><p><img src=\"https://static.tigerbbs.com/a5596cd8cf4db1a7bb5b759d4f269eeb\" tg-width=\"1022\" tg-height=\"459\"></p><p><b>What Happened:</b>&nbsp;The shares surged following positive clinical data announced by a partner of Ocugen and a bullish stance taken by Roth Capital analyst Zegbeh Jallah who has a Buy rating on the stock and a 12-month price target of $10.</p><p>Earlier, on Wednesday, Ocugen’s co-development partner Bharat Biotech said that the second interim analysis of Phase 3 of Covaxin, a COVID-19 vaccine candidate, shows itdemonstrated 78% efficiencyin mild, moderate, and severe disease.</p><p>The vaccine is reportedly 100% effective against severe forms of viral illness.</p><p>In a note, Jallah said that Ocugen has sufficient information to support the filing of an Emergency Use Authorization application in the United States.</p><p>“If granted, this could lead to a significant revenue generating opportunity for Ocugen,” wrote the analyst.</p><p>Jallah said that management has confirmed plans to make Covaxin available in the U.S.</p><p>The vaccine’s initial batches will undergo test and release at a U.S. facility approved by the Food and Drug Administration, as per Jallah.</p><p>Meanwhile, Bharat Biotech isramping up manufacturingto produce 700 million COVID-19 vaccine doses annually.</p><p>Earlier in the month, it was reported that Ocugen plans to sell100 million Covaxin dosesin the U.S.</p><p><b>Price Action:</b>&nbsp;Ocugen shares closed 42.92% higher at $9.29 on Thursday and rose another almost 11% to $10.31 in the after-hours trading.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Ocugen Shares Skyrocketed Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Ocugen Shares Skyrocketed Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-04-23 10:36</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Ocugen Inc</b>&nbsp;OCGN 42.92%&nbsp;shares soared 42.9% in the regular session and another 11% in the after-hours session on Thursday.</p><p><img src=\"https://static.tigerbbs.com/a5596cd8cf4db1a7bb5b759d4f269eeb\" tg-width=\"1022\" tg-height=\"459\"></p><p><b>What Happened:</b>&nbsp;The shares surged following positive clinical data announced by a partner of Ocugen and a bullish stance taken by Roth Capital analyst Zegbeh Jallah who has a Buy rating on the stock and a 12-month price target of $10.</p><p>Earlier, on Wednesday, Ocugen’s co-development partner Bharat Biotech said that the second interim analysis of Phase 3 of Covaxin, a COVID-19 vaccine candidate, shows itdemonstrated 78% efficiencyin mild, moderate, and severe disease.</p><p>The vaccine is reportedly 100% effective against severe forms of viral illness.</p><p>In a note, Jallah said that Ocugen has sufficient information to support the filing of an Emergency Use Authorization application in the United States.</p><p>“If granted, this could lead to a significant revenue generating opportunity for Ocugen,” wrote the analyst.</p><p>Jallah said that management has confirmed plans to make Covaxin available in the U.S.</p><p>The vaccine’s initial batches will undergo test and release at a U.S. facility approved by the Food and Drug Administration, as per Jallah.</p><p>Meanwhile, Bharat Biotech isramping up manufacturingto produce 700 million COVID-19 vaccine doses annually.</p><p>Earlier in the month, it was reported that Ocugen plans to sell100 million Covaxin dosesin the U.S.</p><p><b>Price Action:</b>&nbsp;Ocugen shares closed 42.92% higher at $9.29 on Thursday and rose another almost 11% to $10.31 in the after-hours trading.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137961906","content_text":"Ocugen Inc OCGN 42.92% shares soared 42.9% in the regular session and another 11% in the after-hours session on Thursday.What Happened: The shares surged following positive clinical data announced by a partner of Ocugen and a bullish stance taken by Roth Capital analyst Zegbeh Jallah who has a Buy rating on the stock and a 12-month price target of $10.Earlier, on Wednesday, Ocugen’s co-development partner Bharat Biotech said that the second interim analysis of Phase 3 of Covaxin, a COVID-19 vaccine candidate, shows itdemonstrated 78% efficiencyin mild, moderate, and severe disease.The vaccine is reportedly 100% effective against severe forms of viral illness.In a note, Jallah said that Ocugen has sufficient information to support the filing of an Emergency Use Authorization application in the United States.“If granted, this could lead to a significant revenue generating opportunity for Ocugen,” wrote the analyst.Jallah said that management has confirmed plans to make Covaxin available in the U.S.The vaccine’s initial batches will undergo test and release at a U.S. facility approved by the Food and Drug Administration, as per Jallah.Meanwhile, Bharat Biotech isramping up manufacturingto produce 700 million COVID-19 vaccine doses annually.Earlier in the month, it was reported that Ocugen plans to sell100 million Covaxin dosesin the U.S.Price Action: Ocugen shares closed 42.92% higher at $9.29 on Thursday and rose another almost 11% to $10.31 in the after-hours trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":240,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":376703034,"gmtCreate":1619145940528,"gmtModify":1634288202690,"author":{"id":"3581994063253199","authorId":"3581994063253199","name":"Sharontankh","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581994063253199","idStr":"3581994063253199"},"themes":[],"htmlText":"Buy more","listText":"Buy more","text":"Buy more","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/376703034","repostId":"2129336573","repostType":4,"isVote":1,"tweetType":1,"viewCount":292,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":378959668,"gmtCreate":1618993859754,"gmtModify":1634289356410,"author":{"id":"3581994063253199","authorId":"3581994063253199","name":"Sharontankh","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581994063253199","idStr":"3581994063253199"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/378959668","repostId":"1134733292","repostType":4,"repost":{"id":"1134733292","kind":"news","pubTimestamp":1618993357,"share":"https://www.laohu8.com/m/news/1134733292?lang=&edition=full","pubTime":"2021-04-21 16:22","market":"us","language":"en","title":"Coca-Cola Prices Set To Rise Amid Soaring Cost Pressures","url":"https://stock-news.laohu8.com/highlight/detail?id=1134733292","media":"zerohedge","summary":"The price of a refreshing Coca-Cola is set to rise as the beverage company offsets higher commodity ","content":"<p>The price of a refreshing Coca-Cola is set to rise as the beverage company offsets higher commodity costs.</p>\n<p>A jump in day-to-day business costs for The Coca-Cola Company<i>will result in a price increase of its drinks</i>, CEO James Quincey told&nbsp;CNBC's Sara Eisen on \"Squawk on the Street\"&nbsp;on Monday.</p>\n<p><i>\"We intend to manage those intelligently, thinking through the way we use package sizes and really optimize the price points for consumers,\" Quincey added.</i></p>\n<p>Many of the day-to-day business costs have risen above pre-pandemic levels and could soon chip away at Coca-Cola's margins. Increasing cost pressures are happening when the economy is reopening. Further, the Federal Reserve and the federal government have flooded financial markets and the economy with trillions of dollars, resulting in higher commodity prices.</p>\n<p><img src=\"https://static.tigerbbs.com/1976031f8ab25a4e32a776573d2d22b5\" tg-width=\"500\" tg-height=\"349\"></p>\n<p>Across-the-board increases in costs could eat into corporate margins, and that's why Quincey and his team of corporate execs are planning to hike prices. He did not disclose which Coke products would have higher price tags. Prices of Coke products have already increased thanks to former President Trump's aluminum tariffs.</p>\n<p>The move comes as Kimberly-Clark and J.M. Smucker are increasing the prices of their products to offset rising commodity costs. Also, Procter &amp; Gamble Co will start charging more for household staples this fall.</p>\n<p><i>\"We've already seen some companies' margins narrow, and their ability to restore them will largely depend on whether they can increase prices,\" Michael Hewson, chief market analyst at CMC Markets, told&nbsp;S&amp;P Global.</i></p>\n<p>Morgan Stanley's chief equity strategist&nbsp;published&nbsp;a fresh warning Monday that said \"rising cost pressures/supply shortages, the definitive peak rate of change on economic data and earnings revisions and demand being overwhelmed by supply are all contributing to the deterioration in lower quality, smaller capitalization, and the more cyclical parts of the market.\"</p>\n<p>Sean Darby, the global chief equity strategist at Jefferies, said companies in the first quarter are dealing with some of the<i>\"sharpest year-over-year increases in transport, commodities and raw materials, gasoline prices, etc., in modern history.\"</i></p>\n<p>Making matters worse, consumers are already dealing withrapid food inflationat supermarkets. Now their favorite sugary beverages are about to jump in price.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Coca-Cola Prices Set To Rise Amid Soaring Cost Pressures </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCoca-Cola Prices Set To Rise Amid Soaring Cost Pressures \n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-21 16:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/commodities/coca-cola-prices-set-rise-amid-soaring-cost-pressures?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The price of a refreshing Coca-Cola is set to rise as the beverage company offsets higher commodity costs.\nA jump in day-to-day business costs for The Coca-Cola Companywill result in a price increase ...</p>\n\n<a href=\"https://www.zerohedge.com/commodities/coca-cola-prices-set-rise-amid-soaring-cost-pressures?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"KO":"可口可乐"},"source_url":"https://www.zerohedge.com/commodities/coca-cola-prices-set-rise-amid-soaring-cost-pressures?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134733292","content_text":"The price of a refreshing Coca-Cola is set to rise as the beverage company offsets higher commodity costs.\nA jump in day-to-day business costs for The Coca-Cola Companywill result in a price increase of its drinks, CEO James Quincey told CNBC's Sara Eisen on \"Squawk on the Street\" on Monday.\n\"We intend to manage those intelligently, thinking through the way we use package sizes and really optimize the price points for consumers,\" Quincey added.\nMany of the day-to-day business costs have risen above pre-pandemic levels and could soon chip away at Coca-Cola's margins. Increasing cost pressures are happening when the economy is reopening. Further, the Federal Reserve and the federal government have flooded financial markets and the economy with trillions of dollars, resulting in higher commodity prices.\n\nAcross-the-board increases in costs could eat into corporate margins, and that's why Quincey and his team of corporate execs are planning to hike prices. He did not disclose which Coke products would have higher price tags. Prices of Coke products have already increased thanks to former President Trump's aluminum tariffs.\nThe move comes as Kimberly-Clark and J.M. Smucker are increasing the prices of their products to offset rising commodity costs. Also, Procter & Gamble Co will start charging more for household staples this fall.\n\"We've already seen some companies' margins narrow, and their ability to restore them will largely depend on whether they can increase prices,\" Michael Hewson, chief market analyst at CMC Markets, told S&P Global.\nMorgan Stanley's chief equity strategist published a fresh warning Monday that said \"rising cost pressures/supply shortages, the definitive peak rate of change on economic data and earnings revisions and demand being overwhelmed by supply are all contributing to the deterioration in lower quality, smaller capitalization, and the more cyclical parts of the market.\"\nSean Darby, the global chief equity strategist at Jefferies, said companies in the first quarter are dealing with some of the\"sharpest year-over-year increases in transport, commodities and raw materials, gasoline prices, etc., in modern history.\"\nMaking matters worse, consumers are already dealing withrapid food inflationat supermarkets. Now their favorite sugary beverages are about to jump in price.","news_type":1},"isVote":1,"tweetType":1,"viewCount":204,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"followers","isTTM":false}